232 related articles for article (PubMed ID: 30531139)
1. [Thrombotic microangiopathy developing subsequent to tocilizumab therapy in a patient with TAFRO syndrome].
Ito S; Tsutsumi Y; Kikuchi R; Matsuoka S; Shimoyama N
Rinsho Ketsueki; 2018; 59(11):2432-2437. PubMed ID: 30531139
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of TAFRO syndrome, a variant type of multicentric Castleman disease with thrombotic microangiopathy, with anti-IL-6 receptor antibody and steroids.
Fujiwara S; Mochinaga H; Nakata H; Ohshima K; Matsumoto M; Uchiba M; Mikami Y; Hata H; Okuno Y; Mitsuya H; Nosaka K
Int J Hematol; 2016 Jun; 103(6):718-23. PubMed ID: 26980221
[TBL] [Abstract][Full Text] [Related]
3. Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.
Zhou Q; Zhang Y; Zhou G; Zhu J
BMC Nephrol; 2020 Nov; 21(1):499. PubMed ID: 33225930
[TBL] [Abstract][Full Text] [Related]
4. Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.
Simeni Njonnou SR; Deuson J; Royer-Chardon C; Vandergheynst FA; Wilde V
BMJ Case Rep; 2020 Jun; 13(6):. PubMed ID: 32606113
[TBL] [Abstract][Full Text] [Related]
5. Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.
Leurs A; Gnemmi V; Lionet A; Renaud L; Gibier JB; Copin MC; Hachulla E; Hatron PY; Launay D; Fajgenbaum D; Terriou L
Front Immunol; 2019; 10():1489. PubMed ID: 31316523
[No Abstract] [Full Text] [Related]
6. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
[TBL] [Abstract][Full Text] [Related]
7. Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.
Ozeki T; Tsuji M; Yamamoto J; Shigematsu C; Maruyama S
CEN Case Rep; 2018 Nov; 7(2):243-247. PubMed ID: 29766467
[TBL] [Abstract][Full Text] [Related]
8. Siltuximab Monotherapy in Tafro Syndrome: A Case Report and Review of the Literature.
Cordero L; Aguilar-Rodríguez F; Sandino J; Alonso M; Gutiérrez E
J Nephrol; 2023 May; 36(4):1181-1185. PubMed ID: 36652167
[TBL] [Abstract][Full Text] [Related]
9. Renal histology in a patient with TAFRO syndrome: a case report.
Mizuno H; Sekine A; Oguro M; Oshima Y; Kawada M; Sumida K; Yamanouchi M; Hayami N; Suwabe T; Hiramatsu R; Hasegawa E; Hoshino J; Sawa N; Fujii T; Takaichi K; Ohashi K; Ubara Y
Hum Pathol; 2018 Dec; 82():258-263. PubMed ID: 29626596
[TBL] [Abstract][Full Text] [Related]
10. Thrombocytopenia, Anasarca, Fever, Reticulin Fibrosis/Renal Failure, and Organomegaly (TAFRO) Syndrome with Bilateral Adrenal Hemorrhage in Two Caucasian Patients.
Ducoux G; Guerber A; Durel CA; Asli B; Fadlallah J; Hot A
Am J Case Rep; 2020 Apr; 21():e919536. PubMed ID: 32249274
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of a patient with multicentric Castleman's disease who presented with thrombocytopenia, ascites, renal failure and myelofibrosis using tocilizumab, an anti-interleukin-6 receptor antibody.
Kawabata H; Kotani S; Matsumura Y; Kondo T; Katsurada T; Haga H; Kadowaki N; Takaori-Kondo A
Intern Med; 2013; 52(13):1503-7. PubMed ID: 23812199
[TBL] [Abstract][Full Text] [Related]
12. Tocilizumab-resistant TAFRO Syndrome Complicated by Type II Respiratory Failure.
Aoki T; Wada M; Kawashima A; Hirakawa K; Nagata A; Kagawa K
Intern Med; 2017 Dec; 56(23):3249-3254. PubMed ID: 29021431
[TBL] [Abstract][Full Text] [Related]
13. [Pseudo-adult Still's disease, anasarca, thrombotic thrombocytopenic purpura and dysautonomia: An atypical presentation of multicentric Castleman's disease. Discussion of TAFRO syndrome].
Jouvray M; Terriou L; Meignin V; Bouchindhomme B; Jourdain M; Lambert M; Lefevre G; Hachulla E; Hatron PY; Galicier L; Launay D
Rev Med Interne; 2016 Jan; 37(1):53-7. PubMed ID: 26411598
[TBL] [Abstract][Full Text] [Related]
14. An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy.
Sakashita K; Murata K; Inagaki Y; Oota S; Takamori M
Respirol Case Rep; 2016 Sep; 4(5):e00173. PubMed ID: 27516889
[TBL] [Abstract][Full Text] [Related]
15. Successful Treatment of TAFRO Syndrome, a Variant of Multicentric Castleman's Disease, with Cyclosporine A: Possible Pathogenetic Contribution of Interleukin-2.
Konishi Y; Takahashi S; Nishi K; Sakamaki T; Mitani S; Kaneko H; Mizutani C; Ukyo N; Hirata H; Tsudo M
Tohoku J Exp Med; 2015 Aug; 236(4):289-95. PubMed ID: 26250536
[TBL] [Abstract][Full Text] [Related]
16. A Case of Repeated TAFRO Syndrome-Like Symptoms and Retroperitoneal Hemorrhage in a Patient With Sjögren Syndrome.
Ohta T; Oda N; Saito K; Tamiya S; Ueno T
Cureus; 2020 Dec; 12(12):e12175. PubMed ID: 33489586
[TBL] [Abstract][Full Text] [Related]
17. TAFRO syndrome successfully treated with tocilizumab: A case report and systematic review.
Sakai K; Maeda T; Kuriyama A; Shimada N; Notohara K; Ueda Y
Mod Rheumatol; 2018 May; 28(3):564-569. PubMed ID: 26886414
[TBL] [Abstract][Full Text] [Related]
18. Renal histological continuum of TAFRO syndrome: A case report and literature review.
Uemura T; Matsui M; Kokubu M; Samejima KI; Tsuruya K
Clin Nephrol; 2022 Feb; 97(2):121-128. PubMed ID: 34854374
[TBL] [Abstract][Full Text] [Related]
19. Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.
Sato H; Kanno A; Sato M; Endo A; Ito H; Ohara T; Shirota Y; Sumitomo K; Mori T; Furukawa K
Front Immunol; 2023; 14():1266187. PubMed ID: 37901232
[TBL] [Abstract][Full Text] [Related]
20. The first case of thrombocytopenia, anasarca, fever, renal impairment or reticulin fibrosis, and organomegaly (TAFRO) syndrome with unilateral adrenal necrosis: a case report.
Fujiwara Y; Ito K; Takamura A; Nagata K
J Med Case Rep; 2018 Oct; 12(1):295. PubMed ID: 30293532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]